Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
IRulya Therapeutics Inc. (IRLA) shares: Balyasny Asset Management L.P., BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC, and Dmitry Balyasny may each be deemed to beneficially own 101,604 shares, approximately 9.99% of the class. The reported amount includes 69,281 common shares held directly by Atlas Diversified Master Fund, Ltd. and 32,323 shares issuable upon exercise of warrants and preferred shares.
The warrants and preferred shares are subject to a Beneficial Ownership Limitation that prevents exercise if it would cause the holder to beneficially own more than 9.99% of the shares outstanding as a result of the exercise. The reported percentage is based on 1,017,063 shares outstanding as of August 7, 2026.
Key Figures
Beneficially owned shares:101,604 sharesBeneficial ownership percentage:Approximately 9.99%Common shares held directly:69,281 shares+3 more
6 metrics
Beneficially owned shares101,604 sharesAmount each of the five reporting persons may be deemed to beneficially own
Beneficial ownership percentageApproximately 9.99%Percentage of the class each reporting person may be deemed to own
Common shares held directly69,281 sharesHeld directly by Atlas Diversified Master Fund, Ltd.
Shares issuable upon exercise32,323 sharesIssuable upon exercise of warrants and preferred shares subject to the Beneficial Ownership Limitation
Shares outstanding1,017,063 sharesAs of August 7, 2026, as reported by the issuer
Beneficial Ownership Limitation9.99%Exercise is restricted if it would result in beneficial ownership above this threshold
Key Terms
Beneficial Ownership Limitation, beneficially own, sole dispositive power, Warrants
4 terms
Beneficial Ownership Limitationregulatory
"subject to the Beneficial Ownership Limitation"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
beneficially ownregulatory
"may be deemed to beneficially own such shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
sole dispositive powerregulatory
"Sole Dispositive Power"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Warrantsfinancial
"shares issuable upon the exercise of Warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many IRLA shares did the Balyasny reporting persons report owning?
Each of the five reporting persons may be deemed to beneficially own 101,604 shares, approximately 9.99% of the class. The reported amount includes 69,281 common shares held directly by Atlas Diversified Master Fund, Ltd. and 32,323 shares issuable upon exercise of warrants and preferred shares.
What is the IRLA 9.99% Beneficial Ownership Limitation?
The Beneficial Ownership Limitation prevents exercise of the warrants and preferred shares to the extent an exercise would cause the holder to beneficially own more than 9.99% of the shares outstanding as a result of the exercise.
Who has dividend or sale-proceeds rights in the reported IRLA securities?
Atlas Diversified Master Fund, Ltd., Atlas Private Holdings (Cayman) Ltd., Atlas Private Holdings VIII, LLC, and AEF Plus Privates Fund, LLC have the right to receive dividends or proceeds from the sale of the reported securities.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
IRULYA THERAPEUTICS INC.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
22053A305
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
22053A305
1
Names of Reporting Persons
BALYASNY ASSET MANAGEMENT L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
101,604.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
101,604.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
101,604.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
IA, PN
SCHEDULE 13G
CUSIP Number(s):
22053A305
1
Names of Reporting Persons
BAM GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
101,604.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
101,604.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
101,604.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
HC, OO
SCHEDULE 13G
CUSIP Number(s):
22053A305
1
Names of Reporting Persons
Balyasny Asset Management Holdings LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
101,604.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
101,604.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
101,604.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
HC, PN
SCHEDULE 13G
CUSIP Number(s):
22053A305
1
Names of Reporting Persons
Dames GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
101,604.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
101,604.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
101,604.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
HC, OO
SCHEDULE 13G
CUSIP Number(s):
22053A305
1
Names of Reporting Persons
Dmitry Balyasny
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
101,604.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
101,604.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
101,604.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.99 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
IRULYA THERAPEUTICS INC.
(b)
Address of issuer's principal executive offices:
101 College Street, Suite 210, New Haven, Connecticut 06510
Item 2.
(a)
Name of person filing:
This statement is being filed by (1) Balyasny Asset Management L.P., a Delaware limited partnership ("BAM"), (2) BAM GP LLC, a Delaware limited liability company ("BAM GP"), (3) Balyasny Asset Management Holdings LP, a Delaware limited partnership ("BAM Holdings"), (4) Dames GP LLC, a Delaware limited liability company ("Dames"), and (5) Dmitry Balyasny, a United States citizen (collectively, the "Reporting Persons"). BAM GP is the General Partner of BAM. BAM Holdings is the Sole Member of BAM GP. Dames is the General Partner of BAM Holdings. Dmitry Balyasny is the Managing Member of Dames.
(b)
Address or principal business office or, if none, residence:
The principal business address of each of BAM, BAM GP, BAM Holdings, Dames, and Mr. Balyasny is located at 444 West Lake Street, 50th Floor, Chicago, IL 60606.
(c)
Citizenship:
(1) BAM is a Delaware limited partnership, (2) BAM GP is a Delaware limited liability company, (3) BAM Holdings is a Delaware limited partnership, (4) Dames is a Delaware limited liability company, and (5) Mr. Balyasny is a United States citizen.
(d)
Title of class of securities:
Common Stock, par value $0.001 per share
(e)
CUSIP No.:
22053A305
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
By virtue of its position as the investment manager of Atlas Diversified Master Fund, Ltd. ("ADMF"), the direct holder of the 69,281 shares of common stock, par value $0.001 per share ("Shares"), reported herein, by virtue of its position as the investment manager of Atlas Private Holdings (Cayman) Ltd ("APHC"), the direct holder of preferred shares and shares issuable from the exercise of warrants, by virtue of its position as the investment manager of Atlas Private Holdings VIII, LLC ("APHVIII"), the direct holder of preferred shares and shares issuable from the exercise of warrants, and by virtue of its position as the investment manager of AEF Plus Privates Fund, LLC ("APPF") the direct holder of preferred shares and shares issuable from the exercise of warrants, BAM may be deemed to exercise voting and investment power over such shares held by ADMF, APHC, APHVIII, and APPF and thus may be deemed to beneficially own such shares. By virtue of its position as the General Partner of BAM, BAM GP may be deemed to exercise voting and investment power over the shares held directly by ADMF, APHC, APHVIII, and APPF and thus may be deemed to beneficially own such shares. By virtue of its position as the Sole Member of BAM GP, BAM Holdings may be deemed to exercise voting and investment power over the shares held directly by ADMF, APHC, APHVIII, and APPF and thus may be deemed to beneficially own such shares. By virtue of its position as the General Partner of BAM Holdings, Dames may be deemed to exercise voting and investment power over the shares held directly by ADMF, APHC, APHVIII, and APPF and thus may be deemed to beneficially own such shares. By virtue of his position as the Managing Member of Dames, Mr. Balyasny may be deemed to exercise voting and investment power over the shares held directly by ADMF, APHC, APHVIII, and APPF and thus may be deemed to beneficially own such shares.
(b)
Percent of class:
Each of the Reporting Persons may be deemed to be the beneficial owner of approximately 9.99% of the Shares, based on 1,017,063 Shares outstanding as of Aug. 7, 2026, as reported in the Issuer's report Form10-Q filed with the Securities and Exchange Commission on Aug. 14, 2026. The report amount consists of 69,281 shares and 32,323 shares issuable upon the exercise of Warrants and Preferred Shares each subject to the Beneficial Ownership Limitation (as defined herein). The Warrants and Preferred Shares are subject to a blocker which prevents the holder from exercising to the extent that, upon such exercise, the holder would beneficially own in excess of 9.99% of the Shares outstanding as a result of the exercise (the "Beneficial Ownership Limitation").
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Each of the Reporting Persons has the sole power to vote or to direct the vote of 101604 Shares
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
Each of the Reporting Persons has the sole power to dispose or to direct the disposition of 101604 Shares
(iv) Shared power to dispose or to direct the disposition of:
0
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
ADMF and APHC (both Cayman Islands exempted companies), APHVIII and APPF (both Delaware Limited Liability Companies) are investment management clients of BAM, have the right to receive dividends from, or the proceeds from the sale of, the reported securities.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.